Sponsor:
Effector Therapeutics
Code:
NCT04092673
Conditions
Solid Tumor, Adult
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
eFT226
Sotorasib
Fulvestrant
Abemaciclib
Trastuzumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations